Biofidelity developed a revolutionary molecular diagnostics.
Biofidelity has raised $24.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Biofidelity's investors include Octopus Ventures, SBI Investment, BlueYard Capital, Agilent Technologies, Longwall Venture.
Biofidelity is headquartered in Cambridge, United Kingdom.
Biofidelity developed a revolutionary molecular diagnostics.
Biofidelity is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biofidelity — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/biofidelity. Accessed September 24, 2026.
VCBacked. (2024). Biofidelity — Funding & Investors. Retrieved September 24, 2026, from https://www.vcbacked.co/company/biofidelity
{{cite web |title=Biofidelity — Funding & Investors |url=https://www.vcbacked.co/company/biofidelity |website=VCBacked |access-date=September 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated